Calumet Specialty Products
CLMT
48 hedge funds and large institutions have $30.9M invested in Calumet Specialty Products in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 11 closing their positions.
68% more call options, than puts
Call options by funds: $611K | Put options by funds: $364K
14% more capital invested
Capital invested by funds: $27.1M → $30.9M (+$3.79M)
0.17% more ownership
Funds ownership: 15.23% → 15.39% (+0.17%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9% less funds holding
Funds holding: 53 → 48 (-5)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$489K |
| 2 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
+$343K |
| 3 |
AAA
Adams Asset Advisors
Dallas,
Texas
|
+$210K |
| 4 |
PL
Plancorp LLC
Saint Louis,
Missouri
|
+$116K |
| 5 |
Citigroup
New York
|
+$95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$227K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$170K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$141K |
| 4 |
OCM
Oakwood Capital Management
Los Angeles,
California
|
-$115K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$75.9K |
CLMT Hedge Fund Activity: Q3 2020 in Review
48 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q3 2020, worth a combined $30.9M — up 14% from $27.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CLMT and 6 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 9 added.
The largest buyer was Citadel Advisors, adding an estimated $489K. The largest seller was Morgan Stanley, cutting an estimated $227K.
- 48 institutional investors held Calumet Specialty Products (CLMT) as of Q3 2020, down from 53 in Q2 2020.
- Funds reported $30.9M of Calumet Specialty Products stock for Q3 2020, up 14% quarter-over-quarter.
- 6 funds opened new Calumet Specialty Products positions in Q3 2020 and 11 closed out, a net change of -5 holders.
- The largest Calumet Specialty Products buyer in Q3 2020 was Citadel Advisors, an estimated $489K added.
- The largest Calumet Specialty Products seller in Q3 2020 was Morgan Stanley, an estimated $227K sold.
Based on aggregated 13F filings for Q3 2020.